Role of heavy water in biological sciences with an emphasis on thermostabilization of vaccines

Expert Review of Vaccines

Volumn 8, Issue 11, 2009, Pages 1587-1602

  Sen, Arnab ^a   Balamurugan, Vinayagamurthy ^b   Rajak, Kaushal Kishor ^a   Chakravarti, Soumendu ^a   Bhanuprakash, Veerakyathappa ^a   Singh, Raj Kumar ^c  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b ICAR NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS   (India)

^c NRC on Equine   (India)

Author keywords

heavy water; Stabilization; Veterinary biologicals; Veterinary vaccine

Indexed keywords

ANTIGEN; DEUTERIUM; DEUTERIUM OXIDE; INFLUENZA VACCINE; ISOTOPE; ORAL POLIOMYELITIS VACCINE; PLASMID DNA; SOLVENT; STABILIZING AGENT; VIRUS VACCINE; YELLOW FEVER VACCINE;

ANIMAL HEALTH; BIOCHEMISTRY; BIOLOGY; BIOMEDICINE; BIRD DISEASE; BLOOD; BODY FLUID; CATTLE DISEASE; CELL CULTURE; CELL LINE; CRYOPRESERVATION; EMBRYO (ANATOMY); HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNOWLEDGE; LABORATORY; MEASLES; MEDICAL LITERATURE; MUMPS; NONHUMAN; OUTCOME ASSESSMENT; PH; PLASMA; POLIOMYELITIS; POLYMERASE CHAIN REACTION; POPULATION DYNAMICS; PRIORITY JOURNAL; RABIES; REVIEW; RUBELLA; SAFETY; SERUM; SMALLPOX; SPERM; SURVIVAL; TEMPERATURE; TISSUE WATER; VETERINARY MEDICINE; VIRUS;

BIOLOGICAL SCIENCE DISCIPLINES; DEUTERIUM OXIDE; DRUG STABILITY; HUMANS; POLIOVIRUS VACCINES; PRESERVATION, BIOLOGICAL; PROTEIN STABILITY; VIRAL VACCINES;

EID: 70449413761     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.09.105     Document Type: Review

References (122)

1. Flosdorf EW, Mudd S. Procedure and apparatus for preservation in the lyophile form of serum and other biological substances. J. Immunol. 29, 389-425 (1935).
2. Mariner JC, House JA, Sollod AE et al. Comparision of the effect of various chemical stabilisers and lyophilization cycles on the thermostability of a Vero cell adapted rinderpest vaccine. Vet. Microbiol. 21, 195-209 (1990). •• Landmark paper describing the comparision of three stabilizers, three lyophilization schedules and three diluents at 37°C and three higher temperature ranges: 42, 45 and 56°C. The live-attenuated rinderpest vaccine was used. This is one of the earliest systematically planned studies on the thermostability of a veterinary vaccine.
3. Deboosere'N O, Legeay Y, Caudrelier M et al. Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. Intl. J. Food Microbiol. 93(1), 73-85 (2004).
4. Adams GDJ. Lyophilization of vaccines from methods in molecular medicine. In: Vaccine Protocols (2nd Edition). Robinson A, Hudson MJ, Cranage MP (Eds). Humana Press, NJ, USA (2003). •• An excellent compilation of all relevant topics in the field of vaccinology. The chapter on lyophilization of vaccines is of special interest. The review on temperature-sensitive mutants is also noteworthy.
5. Monath TP. Stability of yellow fever vaccine. Dev. Biol. Stand. 87, 219-225 (1996).
6. 17D lyophilize. I. Essai de substances protectrices. J. Biol. Stand. 12, 435-442 (1984).
7. 17D yellow fever virus vaccine. J. Biol. Stand. 5, 173-179 (1976).
8. Theiler M, Smith HH. The use of yellow fever modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937).
9. 10 potency loss after 3 days of storing the Sabin 3 strain of poliovirus at 45°C. This paper unequivocally describes the importance of heavy water as a candidate for stabilization of live virus vaccine thermostability.
10. Crainic R, Wu R, Otelea D et al. The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine. Dev. Biol. Stand. 87, 161-166 (1996).
11. 2O shows the best stabilizing effect under thermal treatment at 37°C for 24 h.
12. Kauzmann W. Some factors in the interpretation of protein denaturation. Adv. Prot. Chem. 14, 1-63 (1959).
13. Dill KA. Dominant forces in protein folding. Biochem. 29, 7133-7155 (1990).
14. Ernst JA, Clubb RT, Zhou H et al. Demonstration of positionally disordered water within a protein hydrophobic cavity by NMR. Science 267, 1813-1817 (1995).
15. Otting G, Liepinsh E, Wuthrich K. Protein hydration in aqueous solution. Science 254, 974-980 (1991).
16. Denisov VP, Halle B. Protein hydration dynamics in aqueous solution. J. Mol. Biol. 245, 698-709 (1995).
17. Garcia AE, Hummer G. Water penetration and escape in proteins. Proteins Struct. Funct. Genet. 38, 261-272 (2000).
18. Covalt JC, Roy M, Jennings PA. Core and surface mutations affect folding kinetics, stability, and cooperativity I IL-1β: does alteration in buried water play a role? J. Mol. Biol. 307, 657-669 (2001).
19. Papoian GA, Ulander J, Eastwood MP et al. Water in protein structure prediction. Proc. Natl Acad. Sci. USA 101, 3352-3357 (2004).
20. Levy Y, Onuchic JN. Water and proteins: a love-hate relationship. Proc. Natl Acad. Sci. USA 101(10), 3325-3326 (2004).
21. Ludemann HD. Thermodynamic and dynamic properties of water. In: Topics in Molecular and Structural Biology. Neidle S, Fuller W (Eds). Macmillan Press, London, UK, 45-59 (1993).
22. Savage HFJ. Water structure. In: Topics in Molecular and Structural Biology. Neidle S, Fuller W (Eds). Macmillan Press, London, UK, 3-44 (1993).
23. 2O on the resistance of the procollagen to heat denaturation and to the collagenase action. Dokl. Akad. Nauk. SSSR (Biochem.) 220(6), 1445-1448 (1975).
24. Lwoff A, Lwoff M. Effects de l'eau sur le development du poliovirus en function de la temperature. CR Acad. Sci. 251, 3131-3132 (1960).
25. Urey HC, Brickwedde FG, Murphy GM. A hydrogen isotope of mass 2. Phys. Rev. 39, 164-165 (1932).
26. Kushner DJ, Baker A, Dunstall TG. Pharmacological uses and perspectives of heavy water and deuterated compounds. Canadian J. Physiol. Pharmacol. 77(2), 79-88 (1999).
27. Benedict M, Pigford TH, Levi HW. Nuclear Chemical Engineering (2nd Edition). McGraw-Hill, NY, USA (1981).
28. Rae HK. Canada's heavy water story. In: Chemical Engineering in Canada: A Historical Perspective. Shemilt LW (Ed.). Canadian Society of Chemical Engineering, ON, Canada, 334-361 (1991).
29. Miller AT, van Alstyne HM. Heavy water: a distinctive and essential component of CANDU. Atomic Energy of Canada Ltd. report no. 10962, June 1944. pp 11 (1994).
30. Katz JJ. Chemical and biological studies with deuterium. Presented at: 39th Annual Priestley Lecture. Pennsylvania State University, PA, USA, 1-110 (1965).
31. Eisenberg D, Kauzmann W. The Structure and Properties of Water. Clarendon press and Oxford University press, UK (1969).
32. Hogan CJ. Primordial deuterium and the big bang. Sci. Am. 6, 68-73 (1996).
33. Englander SW, Mayne L. Protein folding studied using hydrogen-exchange labeling and two-dimensional NMR. Annu. Rev. Biophys. Biomol. Struct. 21, 243-265 (1992).
34. Paterson Y, Englander SW, Roder H. An antibody binding site on cytochrome C defined by hydrogen exchange and two dimensional NMR. Science 249, 755-759 (1990).
35. Cleland WN, O'Leary MH, Northrop DD. Isotope effects on enzyme-catalyzed reactions. University Park Press, MD, USA, 1-303 (1976).
36. Gillette JR, Darbyshire JF, Sugiyama Y. Theory for the observed isotope effects on the formation of multiple products by different kinetic mechanisms of cytochrome P450 enzymes. Biochem. 33, 2927-2937 (1994).
37. Klein AR, Fernandez VM, Thauer RK. H2-forming N5, N10- methylenetetrahydromethanopterin dehydrogenase: mechanism of H2 formation analyzed using hydrogen isotopes. FEBS Lett. 368, 203-206 (1995).
38. Vanoni MA, Wong KK, Ballou DP et al. Glutathione reductase: comparison of steady-state and rapid reaction primary kinetic isotope effects exhibited by the yeast, spinach and Escherichia coli enzymes. Biochem. 29, 5790-5796 (1990).
39. Hore PJ. Solvent suppression. Methods Enzymol. 176, 64-77 (1989).
40. Markley JL. Two-dimensional nuclear magnetic resonance spectroscopy of proteins: an overview. Methods Enzymol. 176, 12-64 (1989).
41. LeMaster DM. Uniform and selective deuteration in two-dimensional NMR of proteins. Annu. Rev. Biophys. Biophys. Chem. 19, 243-266 (1990).
42. Rösch P. Use of deuterated proteins in nuclear magnetic resonance. Nature 323, 670 (1986).
43. Vanatulu K, Paalme T, Vilu R et al. Large-scale preparation of fully deuterated cell components: ribosomes from Escherichia coli with high biological activity. Eur. J. Biochem. 216, 315-321 (1993).
44. Makhatadze GI, Marius Clore G, Gronenborn AM et al. Solvent isotope effect and protein stability. Nature Struct. Biol. 2, 852-855 (1995).
45. 2O. Biopolymers 85(3), 264-273 (2007).
46. Thomas AF. Deuterium Labeling in Organic Chemistry. Appleton-Century Crofts, NY, USA (1971).
47. Northrop DB. Deuterium and tritium kinetic isotope effects on initial rates. Methods Enzymol. 87, 607-625 (1982).
48. Foster AB. Deuterium isotope effects in the metabolism of drugs and xenobiotics: implications for drug design. Adv. Drug Res. 14, 1-40 (1985).
49. Darbyshire JF, Gillette JR, Nagata K et al. Deuterium isotope effects on A-ring and D-ring metabolism of testosterone by CYP2C11: evidence for dissociation of activated enzyme substrate complexes. Biochem. 33, 2938-2944 (1994).
50. Deraniyagala SA, Adediran SA, Pratt RF. β-secondary and solvent deuterium kinetic isotope effects and the mechanisms of base and acid-catalyzed hydrolysis of penicillanic acid. J. Org. Chem. 60, 1619-1625 (1995).
51. Kushner DJ, Baker A, Dunstall TG. Biotechnological potential of heavy water and deuterated compounds. Proceedings of Biotechnology Risk Assessment Symposium. Ottawa, Canada, 23-25 June 1996. Levin M, Grim C, Angle JA (Eds). University of Maryland Biotechnology Institute Publication 1003, MD, USA, 75-89 (1997). •• Excellent review of the scope and diversity of the application of deuterium in biological sciences. In addition, the production of deuterated glycerol by Dunaleilla spp., a salt-tolerant algae, has been discussed in detail.
52. Buzgariu W, Caloianu M, Lazar S. Structural and ultrastructural changes in fish spleen induced by heavy water. Romanian J. Biol. Sci. 1(IX), 5-6 (1997).
53. Haulica I, Peculea M, Stefanescu I, Titescu GH, Todiras M, Bild W. Effects of heavy and deuterium-depleted water on vascular reactivity. Roman. J. Physiol. 35(1-2), 25-32 (1998).
54. Kritchevsky D. Deuterium in biology. Ann. NY Acad. Sci. 84(16), 575 (1960).
55. Homma Y, Murase Y. Radioactivity in deuterated compounds. J. Radioanal. Nucl. Chem. 146, 205-210 (1990).
56. Covington AK, Robinson RA, Bates RG. The role of deuterium in molecular evolution. J. Phys. Chem. 70, 3820 (1966).
57. Coward WA. Deuterium method for measuring milk intake in babies. Lancet 11, 309 (1979).
58. David S, Engel B, Diskin AM, Spanel P, Davies SJ. Comparative measurements of total body water in healthy volunteers by online breath deuterium measurement and other near-subject methods. Am. J. Clin. Nutr. 76, 1295-1301 (2002).
59. Wells JCK. Energy metabolism in infants and children. Nutrition 14(10), 817-820 (1998).
60. Aleman JO. Gluconeogenesis as a system: development of in vivo flux analysis of hepatic glucose production in type 2 diabetics. PhD thesis in medical engineering submitted to the Massachusetts Institute of Technology, MA, USA (2008).
61. Schutz Y, Deurenberg P. Energy metabolism: overview of recent methods used in human studies. Ann. Nutr. Metab. 40, 183-193 (1996).
62. Klein PD, Klein ER. Stable isotope usage in developing countries: safe tracer tools to measure human nutritional status 'silent tracers' can help health professionals answer some important questions. IAEA Bulletin (4/1987).
63. Katz JJ. The biology of heavy water. Sci. Am. 203, 106-115 (1960).
64. Thomson JF. Biological Effects of Deuterium. Pergamon Press, Macmillan, NY, USA, 133 (1963).
65. Clements CJ, Aguado MT, Jódar L. Technologies to improve immunization safety. Drug Saf. 24(14), 1019-1026 (2001).
66. Arya SC. Human immunization in developing countries - practical and theoretical problems and prospects. Vaccine 12, 1423-1435 (1994).
67. Maa YF, Ameri M, Shu C, Payne LG, Chen DX. Influenza vaccine powder formulation development: spray- freezedrying and stability evaluation. J. Pharm. Sci. 93, 1912-1923 (2004).
68. Worrall EE, Litamoi JK, Seck BM, Ayelet G. Xerovac: an ultra rapid method for the dehydaration and preservation of live attenuated rinderpest and peste des petits ruminants vaccines. Vaccine 19, 834-839 (2000).
69. Lancz G, Sample J. Thermal-pH inactivation of herpes simplex virus: interdependence of the medium composition and the pH on the rate of inactivation. Arch. Virol. 84, 141-146 (1985).
70. Salo RJ, Cliver DO. Effect of pH, salts and temperature on the infectivity and physical integrity of enteroviruses. Arch. Virol. 52, 269-282 (1976).
71. 2- stabilized oral polio vaccine. JAMA 185, 406-408 (1963).
72. Wenzel M. Erhöhte gehirn-affinitiit vonJ-markierten N-(alkyl)-amphetaminen nach deuterierung. J. Labelled Comp. Radiopharm. 27, 1143-1155 (1989).
73. Unno K, Shimba S, Okada S. Modification of thermal response of Chlorella ellipoidea by deuteration. Chem. Pharm. Bull. 37, 3047-3049 (1989). (Pubitemid 20056087)
74. Unno K, Okada S. Alterations in the heat response of Chlorella ellipsoidea by deuteration. Plant Cell Physiol. 32, 113-120 (1991).
75. Unno K, Okada S. Deuteration causes the decreased induction of heat-shock proteins and increased sensitivity to heat denaturation of proteins in Chlorella. Plant Cell Physiol. 35, 197-202 (1994).
76. Yokogaki S, Unno K, Oku N et al. Chaperonin-repairable subtle incompleteness of protein assembly induced by a substitution of hydrogen with deuterium: effect of GroE on deuterated ribulose 1,5-bisphosphate carboxylase. Plant Cell Physiol. 36, 419-423 (1995).
77. Vasdev S, Gupta IP, Sampson CA et al. Deuterium oxide normalizes blood pressure and elevated cytosolic calcium in rats with ethanol-induced hypertension. Canadian J. Cardiol. 9, 802-808 (1993). (Pubitemid 24006122)
78. Vasdev S, Prabhakaran VM, Whelan M, Ford CA, Longerich L, Parai S. Fructose-induced hypertension, hyperglyceridemia and elevated cytosolic calcium in rats: prevention by deuterium oxide. Artery 21, 124-127 (1994).
79. Lin PS, Hefter K, Ho KC. Modification of membrane function, protein synthesis and heat killing effect in cultured Chinese hamster cells by glycerol and D2O. Cancer Res. 44, 5776-5784 (1984). (Pubitemid 15183593)
80. 2O. Biochem. 6, 2474-2488 (1967).
81. McIver DJL, Schurch S, Sridhar R. Deuterium oxide protects against hyperthermic cell death: evidence for role of interfacial water. Physiol. Chem. Phys. 12, 369-372 (1980).
82. 2 O. Arch. Biochem. Biophys. 187, 72-77 (1978).
83. Chow M, Newman JF, Filman D et al. Myristilation of picornavirus capsid protein VP4 and its structural significance. Nature 327, 482-486 (1987). (Pubitemid 17085817)
84. Filman DJ, Syed RM, Chow M et al. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8, 1567-1579 (1989). (Pubitemid 19274384)
85. 2 were able to reduce the interaction of poliovirus with water, hence contributing to thermostabilization.
86. Wallis C, Melnick JL. Cationic stabilization - a new property of enteroviruses. Virology 16, 504-506 (1962).
87. Ikizler MR, Wright PF. Thermostabilization of egg grown influenza virus. Vaccine 20, 1393-1399 (2002). •• Important paper that demonstrates the ability of deuterium oxide to stabilize live-attenuated influenza A and B viruses grown in the allantoic cavity of embryonated eggs. This paper shows the possibility of increasing the potency of inactivated vaccine, which may partially degrade in the inimical environment of allantoic fluid by heavy water.
88. 2O). PhD thesis submitted to deemed university Indian Veterinary Research Institute, Izatnagar, UP, India (2009).
89. Georgescu MM, Delpeyroux F, Tardy- Panit M et al. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 68(12), 8089-8101(1994). (Pubitemid 24362698)
90. Koike S, Taya C, Kurata T et al. Transgenic mice susceptible to poliovirus. Proc. Natl Acad. Sci. USA 88, 951-955 (1991).
91. Children's Vaccine Initiative. Report of: Sixth Meeting Of The Advisory Committee. London, UK, 21-22 April 1994. • Comprehensive review of all aspects of the practical uses of vaccines in children. The aspects of shelf life and thermal degradation are dealt with. The problems associated with adopting deuterium on a large scale are also mentioned.
92. Galazka A, Milstein J, Zaffran M. Thermostability of vaccines. Global programme for vaccines and immunizations. WHO, Geneva, Switzerland (1998). •• Excellent treatise covering the major aspects of thermostability of vaccines. The degradation profiles and mechanisms of preventing thermal degradation using novel and conventional stabilizers are dealt with at length. The importance of vaccine vial monitors is also mentioned.
93. Sarkar J, Sreenivasa BP, Singh RP et al. Comparative efficacy of various chemical stabilizers on the thermostability of live attenuated peste des petits ruminants (PPR) vaccine. Vaccine 21, 4728-4735 (2003). • Brief account of the development of a live-attenuated peste des petits ruminants (PPR) vaccine. The comparative efficacies of conventional sugar-based stabilizers have been assessed, and thermostability studies on a live-attenuated PPR vaccine were performed. A pioneering effort in the field of thermostabilization of the PPR vaccine.
94. Rajendra KB. Current status of DNA vaccines in veterinary medicine. Adv. Drug Deliv. Rev. 43(1), 3-11 (2000).
95. Kaye S, Loveday C, Tedder R. Storage and preservation of whole blood samples for use in detection of human immunodeficiency virus type-1 by the PCR. J. Virol. Methods 35, 217-226 (1991).
96. Zhang L, Wu Q. Single gene retrieval from thermally degraded DNA. J. Biosci. 30(5), 599-604 (2005).
97. Hofmann MA, Thur B, Liu L et al. Rescue of infectious classical swine fever and foot-and-mouth disease virus by RNA transfection and virus detection by RT-PCR after extended storage of samples in Trizol. J. Virol. Methods 87(1-2), 29-39 (2000). (Pubitemid 30345673)
98. Thibier M, Guerin B. Hygienic aspects of storage and use of semen for artificial insemination. Anim. Reprod. Sci. 62(1-3), 233-251 (2000). (Pubitemid 30613276)
99. Balasuriya UBR, Christian M, Leutenegger JB et al. Detection of equine arteritis virus by real-time TaqMan® reverse transcription-PCR assay. J. Virol Methods 101(1-2), 21-28 (2002).
100. Hatanaka H. Clinical results of neutron capture therapy. In: Neutron Beam Design, Development, and Performance for Neutron Capture Therapy (Basic Life Sciences volume 54). Harling OK, Bernard JA, Zamenhof RG (Eds). Pergamon Press, New York, USA and London, UK, 15-21 (1989).
101. Crespi HL. The isolation of deuterated bacteriorhodopsin from fully deuterated Halobacterium halobium. Methods Enzymol. 88, 3-5 (1982).
102. Haon S, Auge S, Tropis M et al. Low cost production of perdeuterated biomass using methylotrophic yeasts. J. Labelled Comp. Radiopharmaceuticals 22, 1053-1063 (1993). (Pubitemid 23317713)
103. 13C) and hydrogen (D) isotope measurements on atmospheric methane and its sources (sinks). Final Report. Institute für Umweltphysik, Heidelberg University, Germany, 1-61 (1991).
104. Smith RB. Deuterium in North Atlantic storm tops. J. Atmos. Sci. 49, 2041-2057 (1992).
105. Jouzel J, Lorius C, Petit JR et al. Vostok ice core: a continuous isotope temperature record over the last climatic cycle (160,000 years). Nature 329, 403-408(1987). (Pubitemid 18317444)
106. Cooper LW, DeNiro MJ. Covariance of oxygen and hydrogen isotopic compositions in plant water: species effects. Ecology 70, 1619-1628 (1989).
107. Ramesh R, Bhattacharya SK, Gopalan K. Dendroclimatological implications of isotope coherence iri trees from Kashmir Valley, India. Nature 317, 802-804 (1985). (Pubitemid 17269084)
108. Kaufmann J, Luethi T, Flisch A et al. First results from the measurement of the distribution of water in building concrete by means of MRI (magnetic resonance imaging) and x-ray computer tomography. Proceedings of the DGZFP Annual Meeting, Innovative Nondestructive Testing - A Challenge to all Sectors of Industry. Fulda, Germany, 27-29 April 1992.
109. Baker MT, Ronnenberg WC Jr, Ruzicka JA et al. Inhibitory effects of deuterium substitutuion on the metabolism of sevoflurane by the rat. Drug Metab. Dispos. 21, 1170-1171 (1993).
110. Shapiro A, Modai Y, Kohn A. Efficacies of vaccines containing alginate adjuvant. J. Appl. Bacteriol. 30(2), 304-311 (1967).
111. Aksan A, Toner M. Isothermal desiccation and vitrification kinetics of trehalosedextran solutions. Langmuir 20, 5521-5529 (2004).
112. Crainic R, Simpson K: Patent WO9421298 (1994).
113. Hamaya T, Horikoshi K: Patent JP01179689 (1989).
114. TEVA PHARM. INDUSTRIES, LTD: EP-332826 (1989).
115. BOEHRINGER SOHN CH CMBH: DE2516836 (1976).
116. Liepins A: Patent US5223269 (1993).
117. Neidrig M, Stahl-Hennig C, Hunsmann G: Intranasal yellow fever vaccination. US6337073 (1998).
118. Abrahamson S, Dinh-Nguyen N, Hellgren LG, Vincent JG: Patent SE426011 B (1982).
119. MERCK AND CO., INC: US4028405 (1977).
120. Heavy water in depth www.sircuitskin.com/heavy-water (Accessed 16 February 2006)
121. Biotechnological potential of heavy water and deuterated compounds www.isb.vt.edu/brarg/brasym96/ kushner96.htm (Accessed 19 July 2009)
122. Heavy water and molecular evolution of life and primordial forms www.scientificblogging.com/olegmosin/ blog/heavy-water-molecular-evolution- and-life-by-dr-oleg-v (Accessed 17 July 2009)